Matches in SemOpenAlex for { <https://semopenalex.org/work/W2311108565> ?p ?o ?g. }
- W2311108565 endingPage "1536" @default.
- W2311108565 startingPage "1524" @default.
- W2311108565 abstract "The current investigation aims to present a novel solid lipid-based nanoparticulate system of resveratrol (RV) for the effective treatment of liver cirrhosis. A simplified solvent injection method was employed and the Box–Behnken experimental design was applied for optimization to get a window particle size of 150–200 nm having maximum entrapment efficiency as well as % release. Optimized resveratrol solid lipid nanoparticles (RV-SLNs) (SR-1) of appropriate characteristics (particle size = 191.1 ± 10.44 nm; zeta potential= −13.56 ± 4.14 mV; entrapment efficiency = 75.23 ± 3.85%; maximum % release = 80.53 ± 3.99%) were produced. Differential scanning calorimetry and X-ray diffraction studies were carried out which collectively proved the reduced crystallinity and stability enhancing the effect of the SLNs. Improved drug stability was further established by the appreciable shelf-life of the formulation from International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)-recommended accelerated stability studies. In vivo studies revealed nearly five-fold increase in the bioavailability of SR-1 (AUC0→∞=3411 ± 170.34 µg/ml/h) as compared to RV suspension (AUC0→∞=653.5 ± 30.10 µg/ml/h). Pharmacodynamic data exhibited a significant decrease in the serum biomarker enzymes (serum glutamic oxalo-acetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and alkaline phosphatase) after oral administration of RV-SLNs as compared to control and marketed (SILYBON®) formulations against paracetamol-induced liver cirrhosis. The effect of the treatment was confirmed by the histopathology of the liver microtome sections. Finally, reverse transcriptase-polymerase chain reaction studies were conducted on isolated liver mRNA from SR-1 treated animals and significant down-regulation of tissue inhibitor of metalloproteinases-1 and nuclear factor-kB was witnessed." @default.
- W2311108565 created "2016-06-24" @default.
- W2311108565 creator A5009125191 @default.
- W2311108565 creator A5041292243 @default.
- W2311108565 creator A5065739147 @default.
- W2311108565 creator A5081164818 @default.
- W2311108565 creator A5087908803 @default.
- W2311108565 date "2016-03-09" @default.
- W2311108565 modified "2023-09-26" @default.
- W2311108565 title "A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics" @default.
- W2311108565 cites W1505142039 @default.
- W2311108565 cites W1768247331 @default.
- W2311108565 cites W1790217901 @default.
- W2311108565 cites W1894938963 @default.
- W2311108565 cites W1961881993 @default.
- W2311108565 cites W1967033368 @default.
- W2311108565 cites W1968835586 @default.
- W2311108565 cites W1969688942 @default.
- W2311108565 cites W1972180606 @default.
- W2311108565 cites W1979501382 @default.
- W2311108565 cites W1983310681 @default.
- W2311108565 cites W1988336925 @default.
- W2311108565 cites W1993009149 @default.
- W2311108565 cites W1995303261 @default.
- W2311108565 cites W1995539371 @default.
- W2311108565 cites W2005976916 @default.
- W2311108565 cites W2006832111 @default.
- W2311108565 cites W2007508593 @default.
- W2311108565 cites W2025375960 @default.
- W2311108565 cites W2027215136 @default.
- W2311108565 cites W2028222947 @default.
- W2311108565 cites W2037340239 @default.
- W2311108565 cites W2062269191 @default.
- W2311108565 cites W2072995534 @default.
- W2311108565 cites W2073069374 @default.
- W2311108565 cites W2077527404 @default.
- W2311108565 cites W2080610214 @default.
- W2311108565 cites W2083172358 @default.
- W2311108565 cites W2084603699 @default.
- W2311108565 cites W2088381487 @default.
- W2311108565 cites W2111092938 @default.
- W2311108565 cites W2127630554 @default.
- W2311108565 cites W2128320208 @default.
- W2311108565 cites W2135892944 @default.
- W2311108565 cites W2136830554 @default.
- W2311108565 cites W2142748292 @default.
- W2311108565 cites W2145706118 @default.
- W2311108565 cites W2148846627 @default.
- W2311108565 cites W2171083652 @default.
- W2311108565 cites W2189070656 @default.
- W2311108565 cites W2320556360 @default.
- W2311108565 cites W991318568 @default.
- W2311108565 doi "https://doi.org/10.3109/03639045.2016.1151032" @default.
- W2311108565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26902951" @default.
- W2311108565 hasPublicationYear "2016" @default.
- W2311108565 type Work @default.
- W2311108565 sameAs 2311108565 @default.
- W2311108565 citedByCount "18" @default.
- W2311108565 countsByYear W23111085652016 @default.
- W2311108565 countsByYear W23111085652017 @default.
- W2311108565 countsByYear W23111085652018 @default.
- W2311108565 countsByYear W23111085652019 @default.
- W2311108565 countsByYear W23111085652020 @default.
- W2311108565 countsByYear W23111085652021 @default.
- W2311108565 countsByYear W23111085652022 @default.
- W2311108565 countsByYear W23111085652023 @default.
- W2311108565 crossrefType "journal-article" @default.
- W2311108565 hasAuthorship W2311108565A5009125191 @default.
- W2311108565 hasAuthorship W2311108565A5041292243 @default.
- W2311108565 hasAuthorship W2311108565A5065739147 @default.
- W2311108565 hasAuthorship W2311108565A5081164818 @default.
- W2311108565 hasAuthorship W2311108565A5087908803 @default.
- W2311108565 hasConcept C112705442 @default.
- W2311108565 hasConcept C150077022 @default.
- W2311108565 hasConcept C150903083 @default.
- W2311108565 hasConcept C170295934 @default.
- W2311108565 hasConcept C181389837 @default.
- W2311108565 hasConcept C185592680 @default.
- W2311108565 hasConcept C199529486 @default.
- W2311108565 hasConcept C207001950 @default.
- W2311108565 hasConcept C2780035454 @default.
- W2311108565 hasConcept C43617362 @default.
- W2311108565 hasConcept C71924100 @default.
- W2311108565 hasConcept C86803240 @default.
- W2311108565 hasConcept C98274493 @default.
- W2311108565 hasConceptScore W2311108565C112705442 @default.
- W2311108565 hasConceptScore W2311108565C150077022 @default.
- W2311108565 hasConceptScore W2311108565C150903083 @default.
- W2311108565 hasConceptScore W2311108565C170295934 @default.
- W2311108565 hasConceptScore W2311108565C181389837 @default.
- W2311108565 hasConceptScore W2311108565C185592680 @default.
- W2311108565 hasConceptScore W2311108565C199529486 @default.
- W2311108565 hasConceptScore W2311108565C207001950 @default.
- W2311108565 hasConceptScore W2311108565C2780035454 @default.
- W2311108565 hasConceptScore W2311108565C43617362 @default.
- W2311108565 hasConceptScore W2311108565C71924100 @default.
- W2311108565 hasConceptScore W2311108565C86803240 @default.
- W2311108565 hasConceptScore W2311108565C98274493 @default.